Overview
Portfolio
More
Meachcove Capital
Cambridge, United States
We deploy capital with founders who have disruptive ideas in food and agriculture.
Portfolio
19+
Employees
N/A
Founded
2022
AUM
N/A
Investment focus
Stages
No stages listed
Industries
No industries listedGeographic scope
United States
Sources
Meachcove Capital
We deploy capital with founders who have disruptive ideas in food and agriculture.
Portfolio
19+
Employees
N/A
Founded
2022
AUM
N/A
Stages
No stages listed
Industries
No industries listedGeographic scope
United States
Sources
Showing 16 of 16 matched portfolio companies
C16 Biosciences utilizes a proprietary biomanufacturing platform to produce high-performance, sustainable alternatives to palm oil, addressing the volatility and environmental concerns associated with traditional palm oil sourcing. Their Palmless™ ingredients enhance product formulations in beauty, personal care, and food, providing secure and natural solutions that meet consumer demand for health and sustainability.
Funding: $33.5M
Rough estimate of the amount of funding raised
Funding: $33.5M
Rough estimate of the amount of funding raised
This company utilizes natural fermentation to cultivate premium, contaminant-free cocoa from selected cacao cells. Their process yields authentic chocolate flavor while ensuring stability and year-round production independent of traditional farming risks. The resulting cocoa is purer and supports forest-friendly, climate-clever sourcing for the food industry.
Funding: $9.0M
Rough estimate of the amount of funding raised
Funding: $9.0M
Rough estimate of the amount of funding raised
This company develops and provides bioscience solutions focused on animal health and sustainable food production. They offer USDA-approved vaccines for honeybees to protect against major diseases and are developing vaccines for shrimp to combat White Spot Syndrome Virus. Their technology leverages natural immune defenses to deliver targeted disease protection across agricultural sectors.
Funding: $6.4M
Rough estimate of the amount of funding raised
Funding: $6.4M
Rough estimate of the amount of funding raised
This startup develops an AI-powered platform for the automated discovery and production of biological robots at a commercial scale. Their technology enables responsive, agential materials to create advanced biological robots that outperform human-engineered tools, offering more efficient applications across various industries.
Groundwork BioAg produces highly concentrated mycorrhizal inoculants (Rootella) that restore fungal networks in cropland, extending root systems up to 100 × to boost yields by 5‑15 % and cut phosphorus fertilizer use by up to 50 %. The inoculants also accelerate permanent soil carbon sequestration, generating 1.5‑3.5 t CO₂e per acre per year, with a carbon‑credit program that returns up to 70 % of net credit proceeds to participating farmers.
The startup produces natural identical animal muscle proteins through precision fermentation using blue-green algae, CO2 from the atmosphere, and sunlight as feedstock. This technology enables the creation of meat and seafood alternatives that minimize environmental impact while providing functional protein sources.
Funding: $2.8M
Rough estimate of the amount of funding raised
Funding: $2.8M
Rough estimate of the amount of funding raised
Liberation Bioindustries operates as a contract manufacturer specializing in precision fermentation at commercial scale to produce specialized ingredients. They provide scalable, cost-effective fermentation capacity for customers across food, pharmaceutical, specialty chemical, and biofuel sectors. The company bridges the gap between R&D and full commercial production by offering reliable, purpose-designed biomanufacturing facilities.
New Culture utilizes traditional cheesemaking techniques combined with modern fermentation technology to produce animal-free mozzarella that mimics the taste and texture of conventional cheese. This process eliminates lactose, cholesterol, hormones, and antibiotics while significantly reducing resource consumption, making it a sustainable alternative in the dairy industry.
Funding: $30.2M
Rough estimate of the amount of funding raised
Funding: $30.2M
Rough estimate of the amount of funding raised
Pow.bio has developed a high-efficiency fermentation platform that decouples biomass growth from product production, addressing issues of contamination and genetic drift in biomanufacturing. This technology enables manufacturers to achieve 2-5 times more product output while reducing production costs by 40-70%.
Funding: $13.9M
Rough estimate of the amount of funding raised
Funding: $13.9M
Rough estimate of the amount of funding raised
Prime Roots produces mycelium-based deli and charcuterie products that retain the flavors of traditional meats while eliminating artificial additives and preservatives. This approach provides a plant-based alternative for meat lovers seeking healthier, sustainable options without compromising on taste.
Funding: $48.5M
Rough estimate of the amount of funding raised
Funding: $48.5M
Rough estimate of the amount of funding raised
Prolific Machines offers a next-generation Cell Line Development platform that integrates optogenetic technology with AI-driven optimization for biomanufacturing. This Photomolecular™ platform uses light to dynamically control cellular processes, significantly boosting titers and improving consistency for difficult-to-express biotherapeutics. The system provides flexible, scalable solutions designed to lower COGS and enhance product quality across antibody and biosimilar production.
Funding: $96.6M
Rough estimate of the amount of funding raised
Funding: $96.6M
Rough estimate of the amount of funding raised
Robigo engineers microbes to create effective and environmentally friendly crop protectants, addressing the significant crop losses of 20-40% due to diseases despite the use of over 6 billion pounds of pesticides annually. By enhancing soil health and increasing farm productivity, Robigo's biomanufacturing solutions promote sustainable agricultural practices.
Funding: $11.5M
Rough estimate of the amount of funding raised
Funding: $11.5M
Rough estimate of the amount of funding raised
Shiru utilizes AI and bioinformatics to discover and develop high-value protein ingredients, significantly reducing the time and cost associated with ingredient discovery. Their ProteinDiscovery.ai marketplace offers tailored, scalable protein solutions that meet diverse functional needs in food and nutrition applications.
Funding: $56.5M
Rough estimate of the amount of funding raised
Funding: $56.5M
Rough estimate of the amount of funding raised
This company provides a Whole Plant Delivery platform that streamlines genome engineering workflows directly within the greenhouse environment. The platform eliminates slow, costly tissue culture steps, enabling partners to move from concept to stable, edited seed in a single plant generation. This accelerates crop improvement timelines by over 70% for food, feed, fuel, and fiber applications.
Wildmicrobes uses synthetic biology to discover and engineer thousands of untapped microbial species from wild environments, creating production strains that synthesize high‑performance ingredients such as emulsifiers, vitamins, and industrial chemicals. Their high‑throughput genomics and bioinformatics pipeline identifies native biosynthetic pathways that reduce raw‑material costs and enable novel molecular functionalities, allowing ingredient manufacturers and specialty chemical producers to replace conventional inputs with renewable, bio‑derived alternatives.
Funding: $3.3M
Rough estimate of the amount of funding raised
Funding: $3.3M
Rough estimate of the amount of funding raised
The startup develops dietary supplements that enhance gut health by converting dietary sugars into plant fiber through specific microbial fermentation processes. This approach aims to improve gastrointestinal function and mitigate diet-related diseases.
10+
1K+Approximate amount of employees
Funding: $3.1M
Rough estimate of the amount of funding raised
Funding: $3.1M
Rough estimate of the amount of funding raised
Showing 3 of 3 unmatched portfolio companies